Original Article
A cost-consequence analysis of the preferential use of secukinumab versus adalimumab for the treatment of psoriatic arthritis
Análisis de las consecuencias en materia de costos del uso preferencial del secukinumab en comparación con el adalimumab para el tratamiento de la artritis psoriásica
Read
2018
Timeswas read the article
740
Total PDF
1278
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 April | 31 | 13 | 44 |
| 2024 March | 42 | 30 | 72 |
| 2024 February | 36 | 32 | 68 |
| 2024 January | 31 | 32 | 63 |
| 2023 December | 41 | 32 | 73 |
| 2023 November | 42 | 39 | 81 |
| 2023 October | 44 | 29 | 73 |
| 2023 September | 212 | 37 | 249 |
| 2023 August | 29 | 12 | 41 |
| 2023 July | 41 | 33 | 74 |
| 2023 June | 45 | 31 | 76 |
| 2023 May | 39 | 22 | 61 |
| 2023 April | 24 | 10 | 34 |
| 2023 March | 85 | 28 | 113 |
| 2023 February | 51 | 31 | 82 |
| 2023 January | 35 | 31 | 66 |
| 2022 December | 68 | 36 | 104 |
| 2022 November | 53 | 36 | 89 |
| 2022 October | 75 | 27 | 102 |
| 2022 September | 50 | 31 | 81 |
| 2022 August | 44 | 39 | 83 |
| 2022 July | 36 | 33 | 69 |
| 2022 June | 52 | 34 | 86 |
| 2022 May | 64 | 40 | 104 |
| 2022 February | 1 | 2 | 3 |
| 2022 January | 1 | 0 | 1 |
| 2021 November | 2 | 2 | 4 |
| 2021 October | 2 | 0 | 2 |
| 2021 May | 1 | 2 | 3 |
| 2021 April | 0 | 6 | 6 |
| 2021 March | 0 | 2 | 2 |
| 2021 January | 0 | 2 | 2 |
| 2020 November | 0 | 3 | 3 |
| 2020 September | 1 | 3 | 4 |
Show all
